Somerset Therapeutics Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 20	Mar ' 19	Mar ' 18	Mar ' 17	Mar ' 16

Sources of funds

Owner's fund

Equity share capital

10.02

10.02

10.02

10.02

10.03

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

-18.19

-14.41

-14.25

-4.35

4.09

Loan funds

Secured loans

23.66

63.95

5.44

6.41

8.29

Unsecured loans

-

-

-

0.25

0.25

Total

15.49

59.57

1.21

12.34

22.66

Uses of funds

Fixed assets

Gross block

123.92

62.59

38.40

35.09

55.21

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

17.37

10.55

6.74

3.42

23.69

Net block

106.55

52.04

31.66

31.67

31.51

Capital work-in-progress

1.41

39.31

6.13

0.05

2.45

Investments

-

-

-

-

-

Net current assets

Current assets, loans & advances

53.53

44.77

34.92

26.36

19.11

Less : current liabilities & provisions

146.00

76.54

71.50

45.74

30.42

Total net current assets

-92.47

-31.77

-36.57

-19.38

-11.31

Miscellaneous expenses not written

-

-

-

-

-

Total

15.49

59.57

1.21

12.34

22.66

Notes:

Book value of unquoted investments

-

-

-

-

-

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

12.04

19.48

33.69

0.39

6.65

Number of equity sharesoutstanding (Lacs)

100.24

100.24

100.24

100.24

100.24